Strategy
MSTR
MARA Holdings
MARA
Tesla
TSLA
Coinbase
COIN
Apple
AAPL
US Stock MarketDetailed Quotes
EYPT EyePoint Pharmaceuticals
- 6.270
- +0.040+0.64%
Close Feb 28 16:00 ET
- 6.270
- 0.0000.00%
Post 20:01 ET
427.93MMarket Cap-3.15P/E (TTM)
6.390High6.000Low640.10KVolume6.170Open6.230Pre Close4.00MTurnover1.49%Turnover RatioLossP/E (Static)68.25MShares27.84052wk High1.96P/B270.02MFloat Cap5.78052wk Low--Dividend TTM43.06MShs Float72.200Historical High--Div YieldTTM6.26%Amplitude2.190Historical Low6.245Avg Price1Lot Size
About EyePoint Pharmaceuticals Company
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Company Profile
SymbolEYPT
Company NameEyePoint Pharmaceuticals
Listing DateJan 27, 2005
Founded1987
CEODr. Jay S. Duker, M.D.
MarketNASDAQ
Employees121
Fiscal Year Ends12-31
Address480 Pleasant Street,Suite A-210
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-926-5000
Company Executives
- Name
- Position
- Salary
- Dr. Jay S. Duker, M.D.
- Director, President and Chief Executive Officer
- 2.92M
- Dr. Ramiro Ribeiro, M.D.,PhD
- Chief Medical Officer
- --
- George O. Elston
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.78M
- Nancy S. Lurker
- Executive Vice Chairman of the Board
- 3.74M
- Dr. Goran A. Ando, M.D.
- Chairman of the Board
- 214.78K
- Dr. John B. Landis, PhD
- Director
- 161.67K
- Dr. Reginald Sanders, M.D.
- Director
- --
- Fred Hassan
- Director
- --
- Stuart M. Duty
- Independent Director
- 381.10K
- Karen Zaderej
- Independent Director
- 149.17K
- Wendy F. DiCicco
- Independent Director
- 171.67K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.